Marker Therapeutics (MRKR) PT Raised to $5.60 at Brookline Capital Markets
Tweet Send to a Friend
Brookline Capital Markets analyst Leah Rush Cann raised the price target on Marker Therapeutics (NASDAQ: MRKR) to $5.60 (from $4.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
